CAPR
insider transactionsCAPRICOR THERAPEUTICS, INC. — buys & sells by directors, officers and 10% owners A shareholder owning more than 10% of the company. Must report trades, but usually a weaker signal than an officer or director. (SEC Form 4).
Net shares · 90d
-222.5K
0 buy · 222.5K sell
Net value · 90d
-$6.8M
$0 in · $6.8M out
Sentiment · 90d
Net selling
0% buying · 100% selling
Open-market trades · 90d
7
0 buy · 222.5K sell
Net buy / sell volume
Not enough data to chart yet.
Tap or hover the chart for daily net volume. Green = net buying, red = net selling.
All transactions
-
Grant·A
CHIEF COMMERCIAL OFFICER
$0
80.0K sh
Own New
-
Exercise·M
Anthony Bergmann KEY
CHIEF FINANCIAL OFFICER
$0
3.0K sh
Own New
-
Exercise·M
Anthony Bergmann KEY
CHIEF FINANCIAL OFFICER
$4.2K
3.0K sh · $1.39
Own +36%
-
Exercise·M
Director
$0
3.9K sh
Own New
-
Exercise·M
Director
$5.5K
3.9K sh · $1.39
Own +3%
-
Exercise·M
EVP, GENERAL COUNSEL · 10b5-1
$0
25.0K sh
Own +80%
-
Sell·S
EVP, GENERAL COUNSEL · 10b5-1
$792.5K
25.0K sh · $31.70
Own -45%
-
Exercise·M
EVP, GENERAL COUNSEL · 10b5-1
$79.5K
25.0K sh · $3.18
Own +82%
-
Exercise·M
Anthony Bergmann KEY
CHIEF FINANCIAL OFFICER · 10b5-1
$0
25.0K sh
Own +27%
-
Sell·S
Anthony Bergmann KEY
CHIEF FINANCIAL OFFICER · 10b5-1
$792.5K
25.0K sh · $31.70
Own -75%
-
Exercise·M
Anthony Bergmann KEY
CHIEF FINANCIAL OFFICER · 10b5-1
$79.5K
25.0K sh · $3.18
Own +304%
-
Exercise·M
Director · 10b5-1
$0
7.5K sh
Own New
-
Sell·S
Director · 10b5-1
$240.9K
7.5K sh · $32.00
Own -100%
-
Exercise·M
Director · 10b5-1
$23.9K
7.5K sh · $3.18
Own New
-
Exercise·M
Director · 10b5-1
$0
53.7K sh
Own New
-
Sell·S
Director · 10b5-1
$1.7M
53.7K sh · $31.03
Own -100%
-
Exercise·M
Director · 10b5-1
$261.2K
53.7K sh · $4.86
Own New
-
Exercise·M
Director · 10b5-1
$0
61.3K sh
Own New
-
Sell·S
Director · 10b5-1
$1.8M
61.3K sh · $30.17
Own -100%
-
Exercise·M
Director · 10b5-1
$297.7K
61.3K sh · $4.86
Own New
-
Exercise·M
EVP, GENERAL COUNSEL · 10b5-1
$0
2.8K sh
Own +4%
-
Exercise·M
EVP, GENERAL COUNSEL · 10b5-1
$0
21.5K sh
Own +41%
-
Exercise·M
EVP, GENERAL COUNSEL · 10b5-1
$0
693 sh
Own +33%
-
Sell·S
EVP, GENERAL COUNSEL · 10b5-1
$752.9K
25.0K sh · $30.12
Own -45%
-
Exercise·M
EVP, GENERAL COUNSEL · 10b5-1
$9.0K
2.8K sh · $3.18
Own +5%
-
Exercise·M
EVP, GENERAL COUNSEL · 10b5-1
$80.4K
21.5K sh · $3.74
Own +69%
-
Exercise·M
EVP, GENERAL COUNSEL · 10b5-1
$963
693 sh · $1.39
Own +2%
-
Exercise·M
Anthony Bergmann KEY
CHIEF FINANCIAL OFFICER · 10b5-1
$0
25.0K sh
Own +21%
-
Sell·S
Anthony Bergmann KEY
CHIEF FINANCIAL OFFICER · 10b5-1
$753.2K
25.0K sh · $30.13
Own -75%
-
Exercise·M
Anthony Bergmann KEY
CHIEF FINANCIAL OFFICER · 10b5-1
$79.5K
25.0K sh · $3.18
Own +304%
| Date▾ | Insider | Type | Shares | Value |
|---|---|---|---|---|
| May 26, 2026 | Michael T Maurer | Grant A | 80.0K | $0 |
| May 18, 2026 | Anthony Bergmann KEY | Exercise M | 3.0K | $0 |
| May 18, 2026 | Anthony Bergmann KEY | Exercise M | 3.0K | $4.2K |
| May 13, 2026 | Frank Litvack | Exercise M | 3.9K | $0 |
| May 13, 2026 | Frank Litvack | Exercise M | 3.9K | $5.5K |
| May 1, 2026 | Karen Krasney 10b5-1 | Exercise M | 25.0K | $0 |
| May 1, 2026 | Karen Krasney 10b5-1 | Sell S | 25.0K | $792.5K |
| May 1, 2026 | Karen Krasney 10b5-1 | Exercise M | 25.0K | $79.5K |
| May 1, 2026 | Anthony Bergmann KEY 10b5-1 | Exercise M | 25.0K | $0 |
| May 1, 2026 | Anthony Bergmann KEY 10b5-1 | Sell S | 25.0K | $792.5K |
| May 1, 2026 | Anthony Bergmann KEY 10b5-1 | Exercise M | 25.0K | $79.5K |
| Apr 2, 2026 | Karimah Es Sabar 10b5-1 | Exercise M | 7.5K | $0 |
| Apr 2, 2026 | Karimah Es Sabar 10b5-1 | Sell S | 7.5K | $240.9K |
| Apr 2, 2026 | Karimah Es Sabar 10b5-1 | Exercise M | 7.5K | $23.9K |
| Apr 1, 2026 | Karimah Es Sabar 10b5-1 | Exercise M | 53.7K | $0 |
| Apr 1, 2026 | Karimah Es Sabar 10b5-1 | Sell S | 53.7K | $1.7M |
| Apr 1, 2026 | Karimah Es Sabar 10b5-1 | Exercise M | 53.7K | $261.2K |
| Mar 31, 2026 | Karimah Es Sabar 10b5-1 | Exercise M | 61.3K | $0 |
| Mar 31, 2026 | Karimah Es Sabar 10b5-1 | Sell S | 61.3K | $1.8M |
| Mar 31, 2026 | Karimah Es Sabar 10b5-1 | Exercise M | 61.3K | $297.7K |
| Mar 31, 2026 | Karen Krasney 10b5-1 | Exercise M | 2.8K | $0 |
| Mar 31, 2026 | Karen Krasney 10b5-1 | Exercise M | 21.5K | $0 |
| Mar 31, 2026 | Karen Krasney 10b5-1 | Exercise M | 693 | $0 |
| Mar 31, 2026 | Karen Krasney 10b5-1 | Sell S | 25.0K | $752.9K |
| Mar 31, 2026 | Karen Krasney 10b5-1 | Exercise M | 2.8K | $9.0K |
| Mar 31, 2026 | Karen Krasney 10b5-1 | Exercise M | 21.5K | $80.4K |
| Mar 31, 2026 | Karen Krasney 10b5-1 | Exercise M | 693 | $963 |
| Mar 31, 2026 | Anthony Bergmann KEY 10b5-1 | Exercise M | 25.0K | $0 |
| Mar 31, 2026 | Anthony Bergmann KEY 10b5-1 | Sell S | 25.0K | $753.2K |
| Mar 31, 2026 | Anthony Bergmann KEY 10b5-1 | Exercise M | 25.0K | $79.5K |
About CAPR insider trading
This page tracks insider transactions for CAPRICOR THERAPEUTICS, INC. (CAPR) reported to the U.S. Securities and Exchange Commission on Form 4. Corporate insiders — directors, executive officers and beneficial owners of more than 10% of the stock — must disclose their trades within two business days. Open-market purchases (code P) and sales (code S) made at the insider's discretion are the most-watched opportunistic signals, while awards (A), option exercises (M) and tax-withholding (F) reflect compensation rather than conviction. Trades marked 10b5-1 were made under a pre-arranged plan and are considered routine. A cluster buy — several insiders buying within a short window — is historically a stronger bullish indicator than any single trade.